Back
Protagonist Therapeutics, Inc. Stock Price Chart
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Sell
50
PTGX
Protagonist Therapeutics, Inc.
Last Price:
$83.01
Seasonality Move:
-2.38%
7 Day Trial
ALL ACCESS PASS
$
7
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Protagonist Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 83.21 | Buy |
| 20-day SMA: | 84.55 | Buy |
| 50-day SMA: | 86.4 | Sell |
| 200-day SMA: | 64.14 | Buy |
| 8-day EMA: | 83.63 | Buy |
| 20-day EMA: | 84.37 | Buy |
| 50-day EMA: | 83.54 | Buy |
| 200-day EMA: | 68.11 | Buy |
Protagonist Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.85 | Sell |
| Relative Strength Index (14 RSI): | 50.46 | Buy |
| Chaikin Money Flow: | 499327 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Protagonist Therapeutics, Inc. Technical Analysis
| Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics, Inc. Stock
Is Protagonist Therapeutics, Inc. Stock a Buy?
-
Protagonist Therapeutics, Inc. share price is 84.79 while PTGX 8-day simple moving average is 83.21, which is a Buy signal.
-
The stock price of PTGX is 84.79 while Protagonist Therapeutics, Inc. 20-day SMA is 84.55, which makes it a Buy.
-
Protagonist Therapeutics, Inc. 50-day simple moving average is 86.40 while PTGX share price is 84.79, making it a Sell technically.
-
PTGX stock price is 84.79 and Protagonist Therapeutics, Inc. 200-day simple moving average is 64.14, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Sell
50
Protagonist Therapeutics, Inc. (PTGX)
is a Sell
Is Protagonist Therapeutics, Inc. a Buy or a Sell?
-
Protagonist Therapeutics, Inc. stock is rated a SellThe current Protagonist Therapeutics, Inc. [PTGX] share price is $84.79. The Score for PTGX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Protagonist Therapeutics, Inc. Stock Info
Market Cap:
5.3B
Price in USD:
84.79
Share Volume:
609.1K
Protagonist Therapeutics, Inc. 52-Week Range
52-Week High:
96.54
52-Week Low:
33.70
Sell
50
Protagonist Therapeutics, Inc. (PTGX)
is a Sell
Protagonist Therapeutics, Inc. Share Price Forecast
-
What is the Protagonist Therapeutics, Inc. stock price today?The Protagonist Therapeutics, Inc. stock price is 84.79 USD today.
-
Will PTGX stock go up or go down?Protagonist Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Protagonist Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics, Inc. is overvalued.
Is Protagonist Therapeutics, Inc. Stock a Buy?
-
Protagonist Therapeutics, Inc. share price is 84.79 while PTGX 8-day exponential moving average is 83.63, which is a Buy signal.
-
The stock price of PTGX is 84.79 while Protagonist Therapeutics, Inc. 20-day EMA is 84.37, which makes it a Buy.
-
Protagonist Therapeutics, Inc. 50-day exponential moving average is 83.54 while PTGX share price is 84.79, making it a Buy technically.
-
PTGX stock price is 84.79 and Protagonist Therapeutics, Inc. 200-day simple moving average is 68.11, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics, Inc.
Is Protagonist Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $1.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.93 per share, and a decrease next year of $1.96 per share.
Technical Analysis of Protagonist Therapeutics, Inc.
Should I short Protagonist Therapeutics, Inc. stock?
-
PTGX Moving Average Covergence Divergence (MACD) indicator is -0.85, suggesting Protagonist Therapeutics, Inc. is a Sell
-
Protagonist Therapeutics, Inc. Relative Strength Index (RSI) is 50.46, which suggest Protagonist Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Protagonist Therapeutics, Inc. is ( - ), which suggest Protagonist Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Protagonist Therapeutics, Inc. is ( - ), which suggest Protagonist Therapeutics, Inc. is a Buy
* Protagonist Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.